PL1694320T3 - Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności - Google Patents
Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywnościInfo
- Publication number
- PL1694320T3 PL1694320T3 PL04806247T PL04806247T PL1694320T3 PL 1694320 T3 PL1694320 T3 PL 1694320T3 PL 04806247 T PL04806247 T PL 04806247T PL 04806247 T PL04806247 T PL 04806247T PL 1694320 T3 PL1694320 T3 PL 1694320T3
- Authority
- PL
- Poland
- Prior art keywords
- acid
- hypersensitivity
- treatment
- hyperreactivity
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03258087 | 2003-12-19 | ||
| EP04806247A EP1694320B1 (en) | 2003-12-19 | 2004-12-17 | Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| PCT/GB2004/005453 WO2005058302A1 (en) | 2003-12-19 | 2004-12-17 | Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1694320T3 true PL1694320T3 (pl) | 2008-11-28 |
Family
ID=34684630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04806247T PL1694320T3 (pl) | 2003-12-19 | 2004-12-17 | Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110229563A1 (pl) |
| EP (1) | EP1694320B1 (pl) |
| JP (1) | JP2007514727A (pl) |
| CN (1) | CN1893937B (pl) |
| AT (1) | ATE400262T1 (pl) |
| DE (1) | DE602004014974D1 (pl) |
| ES (1) | ES2311177T3 (pl) |
| PL (1) | PL1694320T3 (pl) |
| WO (1) | WO2005058302A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107412775B (zh) * | 2010-11-22 | 2021-01-05 | 菲尼克斯生物技术公司 | 用夹竹桃属物种或黄花夹竹桃属物种的提取物治疗神经病症的方法 |
| PT3732994T (pt) | 2013-02-08 | 2022-12-02 | Gen Mills Inc | Produtos alimentares com reduzido teor de sódio |
| KR101645963B1 (ko) * | 2014-05-13 | 2016-08-08 | 주식회사한국야쿠르트 | 사과박(apple pomace)으로부터 우르솔릭산을 고효율로 추출하는 방법 및 그 방법에 의해 추출된 우르솔릭산을 유효성분으로 함유하는 식품조성물 |
| CN104610417B (zh) * | 2015-02-16 | 2016-05-11 | 白心亮 | 一种从山楂中提取熊果酸和齐墩果酸的方法 |
| EP3681477A4 (en) * | 2017-09-14 | 2021-06-09 | Phoenix Biotechnology, Inc. | IMPROVED METHOD AND COMPOSITION FOR THE TREATMENT OF CONDITIONS, DISEASES OR DISORDERS SENSITIVE TO TRITERPENES |
| JP7276745B2 (ja) * | 2019-06-14 | 2023-05-18 | 地方独立行政法人青森県産業技術センター | リンゴ由来トリテルペノイド含有組成物製造方法、ウルソール酸製造方法、およびオレアノール酸製造方法 |
| CN112704663B (zh) * | 2020-12-18 | 2022-07-19 | 吉林农业科技学院 | 一种枇杷叶熊果酸乳膏的制备方法 |
| CN114129572B (zh) * | 2021-12-16 | 2023-04-07 | 南开大学 | 一种协同抑制汉防己甲素诱导的药源性肝损伤的药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03287530A (ja) * | 1990-03-31 | 1991-12-18 | Snow Brand Milk Prod Co Ltd | 免疫抑制剤 |
| JPH1112178A (ja) * | 1997-06-23 | 1999-01-19 | Dainippon Pharmaceut Co Ltd | オレアノール酸系抗掻痒剤 |
| DE60114708T2 (de) * | 2000-06-05 | 2006-07-20 | Loders Croklaan B.V. | Ursolsäure und Oleanolsäure enthaltende Mischungen |
| ATE295087T1 (de) * | 2001-04-09 | 2005-05-15 | Loders Croklaan Bv | Konzentrat von triterpenen |
| JP5081354B2 (ja) * | 2001-11-07 | 2012-11-28 | 株式会社ナリス化粧品 | ＩｇＥ産生抑制剤 |
-
2004
- 2004-12-17 US US10/583,151 patent/US20110229563A1/en not_active Abandoned
- 2004-12-17 JP JP2006544564A patent/JP2007514727A/ja active Pending
- 2004-12-17 WO PCT/GB2004/005453 patent/WO2005058302A1/en active IP Right Grant
- 2004-12-17 CN CN2004800379582A patent/CN1893937B/zh not_active Expired - Fee Related
- 2004-12-17 EP EP04806247A patent/EP1694320B1/en not_active Not-in-force
- 2004-12-17 DE DE602004014974T patent/DE602004014974D1/de active Active
- 2004-12-17 ES ES04806247T patent/ES2311177T3/es active Active
- 2004-12-17 PL PL04806247T patent/PL1694320T3/pl unknown
- 2004-12-17 AT AT04806247T patent/ATE400262T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005058302A1 (en) | 2005-06-30 |
| ES2311177T3 (es) | 2009-02-01 |
| ATE400262T1 (de) | 2008-07-15 |
| EP1694320B1 (en) | 2008-07-09 |
| JP2007514727A (ja) | 2007-06-07 |
| DE602004014974D1 (de) | 2008-08-21 |
| EP1694320A1 (en) | 2006-08-30 |
| US20110229563A1 (en) | 2011-09-22 |
| CN1893937A (zh) | 2007-01-10 |
| CN1893937B (zh) | 2011-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ586759A (en) | Aqueous-alcoholic, single-phase transcutaneous pharmaceutical compositions containing a steroid hormone | |
| EP2638905A3 (en) | Biofilm treatment | |
| MXPA05009933A (es) | Composiciones que comprenden acidos grasos y aminoacidos. | |
| WO2006099121A3 (en) | Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof | |
| WO2006007136A3 (en) | Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease | |
| MX2010007011A (es) | Composicion para alimentacion humana y/o animal, sus usos, y levaduras. | |
| HK1074592A1 (en) | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
| AU2002322421A1 (en) | Improved edible film formulations containing maltodextrin | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
| WO2008118017A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
| MX2009005308A (es) | Composiciones que comprenden peroxido de benzoilo, al menos un derivado del acido naftoico y al menos un compuesto del tipo polimeros de poliuretano o derivados de estos y sus usos. | |
| WO2007064968A3 (en) | Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate | |
| WO2009077693A3 (fr) | Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene | |
| EP1852114A4 (en) | COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS | |
| WO2007018588A8 (en) | Stable pharmaceutical composition comprising linezolid form iv | |
| HRP20120228T1 (hr) | Kladribinski režim za liječenje multiple skleroze | |
| MX2017006813A (es) | Composicion farmaceutica, preparacion y usos de la misma. | |
| PL1694320T3 (pl) | Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności | |
| RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| NO20053788L (no) | Anvendelse av lupin-konglutin for behandlingen av type II diabetes. | |
| MY130792A (en) | 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | |
| MY153109A (en) | A solid pharmaceutical formulation |